{
    "clinical_study": {
        "@rank": "134714", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients\n      with primary hyperhidrosis."
        }, 
        "brief_title": "Study of Botulinum Toxin in Patients With Primary Hyperhidrosis", 
        "condition": "Hyperhidrosis", 
        "condition_browse": {
            "mesh_term": "Hyperhidrosis"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients receive injections of botulinum toxin in the clinical trial for 6 months.  Patients\n      undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of\n      the drug.  Patients also complete questionnaires to evaluate the amount of sweating."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Diagnosis of hyperhidrosis\n\n          -  Excessive sweating in the hands, feet, armpits, forehead, or body"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004480", 
            "org_study_id": "199/14182", 
            "secondary_id": [
                "MTS-GCO-98-913NE", 
                "ALLERGAN-MTS-GCO-98-913NE"
            ]
        }, 
        "intervention": {
            "intervention_name": "botulinum toxin type A", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "keyword": [
            "dermatologic disorders", 
            "hyperhidrosis", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10029"
                }, 
                "name": "Mount Sinai School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Horacio Kaufmann", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004480"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2004"
    }, 
    "geocoordinates": {
        "Mount Sinai School of Medicine": "40.714 -74.006"
    }
}